Drugs / Trelegy
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06474039 | Oct 2024 → Jun 2026 overdue | chronic obstructive pulmonary disease | Mahidol University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trelegy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06474039 ↗ |
| Route | Inhaled | “Both drugs delivered via Ellipta device and blinded package appearance” NCT06474039 ↗ |